A quantitative detection system for measuring insulin-like growth factor binding protein-1 and fetal fibronectin levels. This system is used for combined quantitative analysis of these biomarkers.
Manufactured by
Anhui Huibang Biological Engineering Co., Ltd.
China
National high-tech enterprise established in 2013, specializing in precision medicine diagnostics. Product lines include diabetic nephropathy tests, maternal and child health diagnostics, cardiovascular disease markers, tumor markers, and monoclonal antibody raw materials. Holds over 40 national patents with total investment of 450 million RMB.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Guangdong Ascendas Genomics Technology Co., Ltd.
China · 1 relevant product
Shenzhen Kingfocus Biomedical Engineering Co., Ltd.
China · 2 relevant products
DiaSys Diagnostic Systems GmbH
Germany · 1 relevant product
10 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →4 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
2 of 2 relevant matches
Shenzhen Microprofit Biotech Co., Ltd · China
Complete point-of-care fluorescence immunoassay system for quantitative biomarker measurement. Supports multiple test kits and provides rapid turnaround results.
Wiener lab. · Brazil
Analyzers for quantifying plasma fibrinogen levels. These systems assess coagulation status and bleeding disorder risk.
© 2026 Suplivia · Home · Browse Products